A major haemorrhage protocol improves the delivery of blood component therapy and reduces waste in trauma massive transfusion

BackgroundMajor haemorrhage protocols (MHP) are required as part of damage control resuscitation regimens in modern trauma care. The primary objectives of this study were to ascertain whether a MHP improved blood product administration and reduced waste compared to traditional massive transfusion protocols (MTP).MethodsDatasets on adult trauma admissions 1 year prior and 1 year post implementation of a MHP at a Level 1 trauma centre were obtained from the trauma registry. Demographic and clinical data were collected prospectively including mechanism of injury, physiological observations, ICU admission and length of stay. The volume of blood components (packed red blood cells, platelets, cryoprecipitate and fresh frozen plasma) issued, transfused, returned to stock and wasted within the first 24 h was gathered retrospectively.ResultsOver the 2-year study period 2986 patient records were available for analysis. 40 patients required a 10+ Units of packed red blood ells transfusion in the MTP group vs. 56 patients post MHP implementation. The administration of blood component therapy improved significantly post MHP implementation. FFP:PRBC transfusion improved from 1:3 to 1:2 (p < 0.01) and CRYO:PRBC improved from 1:10 to 1:7 (p < 0.05). We reported a significant reduction in the waste of platelets from 14% to 2% (p < 0.01). Outcomes had improved: Median hospital length of stay was reduced from 54 days to 26 days (p < 0.05).ConclusionImplementation of a MHP results in improved delivery of blood components and a reduction in the waste of blood products compared to the older model of MTP. In combination with educational programmes MHP can significantly improve blood product administration and patient outcomes in trauma haemorrhage.Level of evidenceLevel III diagnostic test study.